跳至主要内容
临床试验/PER-040-04
PER-040-04已完成未知

CONTROLLED STUDY OF TWO COMPONENTS OF FERROUS POLYMOTHERAPY IN THE TREATMENT OF FERROPENIC ANEMIA IN CHILDREN FROM 6 MONTHS TO 2 YEARS OLD

ABL PHARMA PERU,0 个研究点目标入组 0 人开始时间: 2004年7月21日最近更新:

试验速览

阶段
未知
状态
已完成
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
0 至 0(—)

入选标准

  • 1. You must have the consent of informed consent.
  • 2. Have an age between 6 months and 2 years.
  • 3. Hemoglobin> 8 and <11 g / dl. and / or decreased serum Ferritin
  • 4. Be able to attend the consultation according to the study schedule.
  • 5. Be included between the 10-90 percentiles, age-statural for age and sex according to the NCHS tables.

排除标准

  • 1. History of intolerance to iron salts.
  • 2. History of chronic anemia resistant to treatment.
  • 3. Acute or chronic pathologies that can modify the blood values.
  • 4. Intestinal parasitosis detected by simple direct examination at the time of onset
  • of the study.
  • 5. Need to use medications that can modify the blood values.
  • 6. History of blood discies.
  • 7. History of liver or kidney pathology.

研究者

发起方
ABL PHARMA PERU,

相似试验